相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CFTR function, pathology and pharmacology at single-molecule resolution
Jesper Levring et al.
NATURE (2023)
The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches
Simon Y. Graeber et al.
LANCET (2023)
Mechanism of CFTR correction by type I folding correctors
Karol Fiedorczuk et al.
CELL (2022)
Proximity Profiling of the CFTR Interaction Landscape in Response to Orkambi
Melissa Iazzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
ProteinsPlus: a comprehensive collection of web-based molecular modeling tools
Katrin Schoening-Stierand et al.
NUCLEIC ACIDS RESEARCH (2022)
Molecular structures reveal synergistic rescue of Δ508 CFTR by Trikafta modulators
Karol Fiedorczuk et al.
SCIENCE (2022)
Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator
Onofrio Laselva et al.
ISCIENCE (2021)
Phenotyping Rare CFTR Mutations Reveal Functional Expression Defects Restored by TRIKAFTA™
Onofrio Laselva et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Cystic fibrosis in the year 2020: A disease with a new face
Kris De Boeck
ACTA PAEDIATRICA (2020)
A Therapy for Most with Cystic Fibrosis
Christine E. Bear
CELL (2020)
Accumulation and persistence of ivacaftor in airway epithelia with prolonged treatment
Tara N. Guhr Lee et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
The bidirectional relationship between CFTR and lipids
Kirsten A. Cottrill et al.
COMMUNICATIONS BIOLOGY (2020)
Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770
Han- Yeh et al.
JOURNAL OF GENERAL PHYSIOLOGY (2019)
Structural identification of a hotspot on CFTR for potentiation
Fangyu Liu et al.
SCIENCE (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski's Rule of Five
Caroline Manto Chagas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Lipophilicity of the Cystic Fibrosis Drug, Ivacaftor (VX-770), and Its Destabilizing Effect on the Major CF-causing Mutation: F508del
Stephanie Chin et al.
MOLECULAR PHARMACOLOGY (2018)
Treating Specific Variants Causing Cystic Fibrosis
Garry R. Cutting
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics
Alison E. Fohner et al.
PHARMACOGENETICS AND GENOMICS (2017)
Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia
Saumel Ahmadi et al.
NPJ GENOMIC MEDICINE (2017)
Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor)
Elizabeth Matthes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
Gudio Veit et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
Miqueias Lopes-Pacheco
FRONTIERS IN PHARMACOLOGY (2016)
Progress in therapies for cystic fibrosis
Kris De Boeck et al.
LANCET RESPIRATORY MEDICINE (2016)
Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening
Rodrigo Quiroga et al.
PLOS ONE (2016)
Organomediated Enantioselective 18FFluorination for PET Applications
Faye Buckingham et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Developing diazirine-based chemical probes to identify histone modification 'readers' and 'erasers'
Tangpo Yang et al.
CHEMICAL SCIENCE (2015)
Protein Traffic Disorders: an Effective High-Throughput Fluorescence Microscopy Pipeline for Drug Discovery
Hugo M. Botelho et al.
SCIENTIFIC REPORTS (2015)
Discovery of N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator
Sabine Hadida et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression
Guido Veit et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
Deborah M. Cholon et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
PKP-017 Monitoring of ivacaftor serum levels
R Trittler et al.
European Journal of Hospital Pharmacy-Science and Practice (2014)
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
Michael P. Boyle et al.
LANCET RESPIRATORY MEDICINE (2014)
HEK-293 cells expressing the cystic fibrosis transmembrane conductance regulator (CFTR): a model for studying regulation of Cl- transport
Jada C. Domingue et al.
PHYSIOLOGICAL REPORTS (2014)
A Rapid Membrane Potential Assay to Monitor CFTR Function and Inhibition
Rangan Maitra et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus
Yue-Lei Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
The influence of lipophilicity in drug discovery and design
John A. Arnott et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Inhibition of Glyoxalase I: The First Low-Nanomolar Tight-Binding Inhibitors
Swati S. More et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels
Beate Illek et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2008)
Cystic fibrosis since 1938
PB Davis
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Copper(I) mediated cross-coupling of amino acid derived organozinc reagents with acid chlorides
T Hjelmgaard et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2006)
CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains
P Vergani et al.
NATURE (2005)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Isolation of CF cell lines corrected at ΔF508-CFTR locus by SFHR-mediated targeting
E Bruscia et al.
GENE THERAPY (2002)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
